Mobile
Search
Advanced search
Multi-criteria search
Who are we ?
Log in
Sign up
Français
English
Kusajili – Clinical trials directory
Send this study to a contact
1
Your personal information
Your name
Your e-mail
Send me a copy
2
Your recipient's information
The name of your contact
Your contact email
3
Your message
Votre message
12-month open label, randomized, multicenter study evaluating efficacy, safety and tolerability of oral AEB071 plus tacrolimus (converted to myfortic after 3 months), vs. myfortic plus tacrolimus in de novo renal transplant recipients https://www.kusajili.fr:443/Trial/AdAlwjio8kGIbLPoF16A6Q%2412-month-open-label-randomized-multicenter-study-evaluating-efficacy-safety-and-tolerability-of-oral-aeb071-plus-tacrolimus-con
I have read and accept the terms of use of the site and the Privacy Policy
Send your message